Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+23.4%
5Y CAGR+33.1%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
+23.4%/yr
vs +16.8%/yr prior
5Y CAGR
+33.1%/yr
Recent deceleration
Acceleration
+6.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $150.73M | +618.0% |
| 2023 | $20.99M | -37.1% |
| 2022 | $33.37M | -58.4% |
| 2021 | $80.21M | +83.3% |
| 2020 | $43.76M | +21.2% |
| 2019 | $36.11M | -48.6% |
| 2018 | $70.25M | +62.9% |
| 2017 | $43.12M | +647.5% |
| 2016 | $5.77M | -73.4% |
| 2015 | $21.66M | - |